Cargando…
Predictive biomarkers for the responsiveness of recurrent glioblastomas to activated killer cell immunotherapy
BACKGROUND: Recurrent glioblastoma multiforme (GBM) is a highly aggressive primary malignant brain tumor that is resistant to existing treatments. Recently, we reported that activated autologous natural killer (NK) cell therapeutics induced a marked increase in survival of some patients with recurre...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9875464/ https://www.ncbi.nlm.nih.gov/pubmed/36694264 http://dx.doi.org/10.1186/s13578-023-00961-4 |